DBV Technologies (DBVT) Enterprise Value (2015 - 2026)
DBV Technologies (DBVT) posted quarterly Enterprise Value of -$174.9 million for Q2 2026, down 69.47% year-on-year from -$572.8 million in Q2 2025, and up 23.69% on a QoQ basis from -$229.2 million in Q1 2026.
DBV Technologies (DBVT) Enterprise Value (2015 - 2026) Analysis & Trends
DBV Technologies (DBVT) has reported Enterprise Value for 12 consecutive years, with -$174.9 million the latest figure, recorded in Q2 2026.
- Quarterly Enterprise Value fell 69.47% year-over-year to -$174.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$174.9 million (down 69.47% YoY) and the FY2025 annual result came in at -$194.2 million, down 498.35% from the prior year.
- Enterprise Value grew to -$174.9 million in Q2 2026 per DBVT's latest filing, from -$229.2 million in the prior quarter.
- Over the last five years, Enterprise Value for DBVT reached as high as -$13.0 million in Q1 2025 and fell as low as -$248.0 million in Q2 2022.
- A 5-year average of -$135.1 million and a median of -$145.3 million in 2023 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2025 — Enterprise Value soared 87.23% — and 2026, when it slumped 1668.25%.
- Year by year, Enterprise Value stood at -$209.2 million in 2022, then soared by 32.42% to -$141.4 million in 2023, then surged by 77.04% to -$32.5 million in 2024, then slumped by 498.35% to -$194.2 million in 2025, then rose by 9.94% to -$174.9 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$174.9 million, -$229.2 million, and -$194.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - | -174.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -174.90 Mn |
| Mar 31, 2026 | -229.20 Mn |
| Dec 31, 2025 | -194.20 Mn |
| Sep 30, 2025 | -69.84 Mn |
| Jun 30, 2025 | -103.21 Mn |
| Mar 31, 2025 | -12.96 Mn |
| Dec 31, 2024 | -32.46 Mn |
| Sep 30, 2024 | -46.44 Mn |
| Jun 30, 2024 | -66.21 Mn |
| Mar 31, 2024 | -101.53 Mn |
| Dec 31, 2023 | -141.37 Mn |
| Sep 30, 2023 | -149.14 Mn |
| Jun 30, 2023 | -173.96 Mn |
| Mar 31, 2023 | -192.29 Mn |
| Dec 31, 2022 | -209.19 Mn |
| Sep 30, 2022 | -212.67 Mn |
| Jun 30, 2022 | -247.97 Mn |
| Mar 31, 2022 | -74.11 Mn |
| Dec 31, 2021 | -77.30 Mn |
| Sep 30, 2021 | -98.20 Mn |